Fundraising Fox

Osman Ozes

Founder

Founder at Altay Therapeutics

San Bruno, California, United States

FoundedAltay Therapeutics · YC

About

Osman Ozes is the Founder and Chief Scientific Officer of Altay Therapeutics, with over 30 years of academic and 10 years of industry research experience across fibrosis, cancer immunology, inflammatory diseases, and biomarkers. As Director of Research at Intermune Inc., he characterized the mechanism of action of Pirfenidone (Esbriet) using bioassays he developed and patented, work that contributed to the drug's FDA approval for lung fibrosis, and he handled regulatory documentation including CMC filings, IMPDs/INDs, and MAAs/BLAs. At Altay Therapeutics, he helped develop a platform for identifying small molecule binding sites in transcription factors and advanced three first-in-class assets targeting idiopathic pulmonary fibrosis, Ewing's Sarcoma, and facioscapulohumeral muscular dystrophy.

Founder at Altay TherapeuticsYC W20

Intro paths

YC

Osman went through Y Combinator (Winter 2020) — any YC alum in your network can reach them through the YC community.

→

In turn, Osman can intro founders to Altay Therapeutics's investors below.

Altay Therapeutics's investors · 5

Creative Destruction Lab (CDL)Toronto · $50K – $250K checksNational Institutes of Health (NIH)since 2022National Science FoundationAlexandria · since 2023Tachyon VenturesLos AngelesY CombinatorSan Francisco · $500K checks · since 2020

Co-founders at Altay Therapeutics

AOAli Ozes
Ali OzesFounder

Experience

  1. Altay TherapeuticsFounder and Chief Scientific Officercurrent2019 — present455 Mission Bay Boulevard South, San Francisco CA
  2. Nalo TherapeuticsScientific Consultant2018 — 2019
  3. Akdeniz UniversityProfessor2009 — 2018Akdeniz University, Antalya Turkey
  4. Teva PharmaceuticalsScientific Advisor2014 — 2017
  5. InterMune (Acquired by Roche)Director of Research2002 — 2007San Francisco Bay Area
  6. Indiana UniversityPostdoctoral Fellow1997 — 2002Walther oncology center IUPUI

Skills & more

Grant Writing3research5Biotechnology Industry1Drug Discovery3Molecular & Cellular BiologyMolecular OncologyPublic Speaking

Languages English · Turkish

From Osman's professional profile.

Frequently asked questions

Who is Osman Ozes?
Osman Ozes is the Founder and Chief Scientific Officer of Altay Therapeutics, with over 30 years of academic and 10 years of industry research experience across fibrosis, cancer immunology, inflammatory diseases, and biomarkers. As Director of Research at Intermune Inc., he characterized the mechanism of action of Pirfenidone (Esbriet) using bioassays he developed and patented, work that contributed to the drug's FDA approval for lung fibrosis, and he handled regulatory documentation including CMC filings, IMPDs/INDs, and MAAs/BLAs. At Altay Therapeutics, he helped develop a platform for identifying small molecule binding sites in transcription factors and advanced three first-in-class assets targeting idiopathic pulmonary fibrosis, Ewing's Sarcoma, and facioscapulohumeral muscular dystrophy.
Where does Osman Ozes work?
Osman Ozes is Founder of Altay Therapeutics.
What companies did Osman Ozes found?
Osman Ozes founded Altay Therapeutics.
Where did Osman Ozes go to school?
Osman Ozes studied at Indiana University Bloomington (PhD Student. Department of Molecular Biology, Microbiology and Immunology); Hacettepe University (Masters Student, Department of Molecular Biology); Hacettepe University (Bachelor of Science (BS) Molecular Biology, Medical Microbiology and Bacteriology).

Founder mafias

Y Combinator mafia9,496

Also came through, then founded or led a company.

Sam AltmanPresidentFounded Tools for Humanity +3Garry TanPresident & CEOFounded Y Combinator +1Jessica LivingstonCo-founderFounded Y CombinatorAlexis OhanianYC Summer 2005Founded RedditFred EhrsamYC Summer 2012Founded Nudge +1Matt HuangYC Winter 2011Founded Hotspots

+ 9,489 more

Indiana University Bloomington mafia50

Also came through, then founded or led a company.

Darren NixFounded Steadily +2Eric TobiasFounded Opendate +1Michael McHughBachelor's degreeFounded Blockstamp +1James O'DwyerBachelor of Science (B.S.)Founded Metal +1Bradley BosticBSFounded Hc1 +1Jamie BacherFounded Boost Biomes

+ 43 more

Hacettepe University mafia3

Also came through, then founded or led a company.

Sevgi GurkanDoctor of Medicine (M.D.)Founded Perfuse TherapeuticsYusuf ErkulDoctor of Medicine (M.D.)Founded Kernal Biologics

Same school

Also attended Indiana University Bloomington224

Tianen LiangTax Controller at Felicis VenturesDavid KraneCEO & Managing Partner at GV (Google Ventures)Keren GottliebEvent Manager at GreycroftLogan HilleLife Sciences Analyst at CincyTechJay JohnsonBoard Member at CincyTechEric TobiasInvestor at High Alpha

+ 218 more

Also attended Hacettepe University12

Tanzila SharifliOperations | Marketing & Outreach at 212İmran GürakanCEO at Leap InvestmentAkcan IstifHead of Innovation & Labs at Scientifica Venture CapitalIsmet YaziciE.V.P. Business Development at Wesley Clover International CorporationEmre ÖlçerInvestment Committee at Arya VenturesElif Can İnalkoç GedikliInvestment Director, Board Member and Investment Committee Member at Teknoloji Yatirim

+ 6 more

Shared employers

Also worked at Altay Therapeutics1

Ali OzesFounder at Altay Therapeutics

Also worked at Teva Pharmaceuticals31

Catherine Pearce, DHSc, MBAAdvisor at CincyTechElad BaronInvestment Professional at Key1 CapitalElaine ShannonPresident, Global Supply & Quality at Takeda VenturesRiki MozesVice President, Chief People Officer at Jerusalem Venture Partners (JVP)Jill DeSimoneDigital Pharma Advisor at Excelerate Health VenturesPerry NisenExecutive Advisor, Private Equity at Sofinnova Ventures

+ 25 more

Also worked at Indiana University23

Logan HilleLife Sciences Analyst at CincyTechKyle PrifogleStaff AI Engineer at JMI EquityDanisha PasayaAnalyst, M&A Advisory at eGateway CapitalRachel ByrneSenior Talent Manager at Mainsail PartnersAnnie BrennanSenior Associate, Information Technology at Adams Street PartnersSeth NuttPrincipal at Griffin Gaming Partners

+ 17 more